Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Johnson & Johnson
< Previous
1
2
3
4
5
Next >
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
September 18, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Marks New Era as Global Healthcare Company With Updated Visual Identity
September 14, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation
August 30, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Final Results of Exchange Offer and Finalizes Separation of Kenvue Inc.
August 23, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
KVUE
Johnson & Johnson to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
August 22, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Preliminary Results of Kenvue Inc. Exchange Offer
August 21, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
KVUE
Johnson & Johnson Announces Final Exchange Ratio of 8.0324 in Split-Off of Kenvue Inc.
August 16, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
KVUE
Johnson & Johnson to Participate in the 2023 Wells Fargo Securities Healthcare Conference
August 07, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Launches Exchange Offer for Separation of Kenvue Inc.
July 24, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2023
July 20, 2023
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Reports Q2 2023 Results
July 20, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the UBS MedTech, Tools and Genomics Summit
July 10, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
June 06, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
May 10, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering
May 03, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Bernstein 39th Annual Strategic Decisions Conference
April 25, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Launch of Kenvue Inc. IPO Roadshow
April 24, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Dividend Increase of 5.3%
April 18, 2023
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Reports Q1 2023 Results
April 18, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Subsidiary LTL Management LLC (“LTL”) Re-Files for Voluntary Chapter 11 to Equitably Resolve All Current and Future Talc Claims
April 04, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
March 15, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature
March 15, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Pricing of $7.75 Billion of Senior Notes Issued by Kenvue Inc.
March 08, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to its Board of Directors
February 14, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Barclays Global HealthCare Conference
February 14, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D
February 13, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Cowen 43rd Annual HealthCare Conference
February 02, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Reports Q4 and Full-Year 2022 Results
January 24, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference
January 18, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2023
January 03, 2023
From
Johnson & Johnson
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
